featured
Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Urology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer: Preliminary Findings From the PURE-01 Study
Eur Urol 2019 Dec 24;[EPub Ahead of Print], A Necchi, M Bandini, G Calareso, D Raggi, F Pederzoli, E Farè, M Colecchia, L Marandino, M Bianchi, A Gallina, R Colombo, N Fossati, G Gandaglia, U Capitanio, F Dehò, P Giannatempo, R Lucianò, A Salonia, R Madison, SM Ali, JH Chung, JS Ross, A Briganti, F Montorsi, F De Cobelli, A MessinaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.